Phase 1 tolerability and antiamoebic activity studies with 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone (Go. 10213): a new antiprotozoal agent

Journal article

Open access

Peer reviewed

A. B Vaidya, D. K Ray, N. A Mankodi, T Paul and U. K Sheth

British journal of clinical pharmacology, v 16(5), pp 517-522

1983

PMID: 6639838

Files and links (1)

url

https://doi.org/10.1111/j.1365-2125.1983.tb02209.xView

Published, Version of Record (VoR)Open Access (License Unspecified), Open

Antibiotics. Antiinfectious agents. Antiparasitic agents

Antiparasitic agents

Biological and medical sciences

Medical sciences

Pharmacology. Drug treatments

7 Record Views

11 citations in Scopus

Title: Phase 1 tolerability and antiamoebic activity studies with 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone (Go. 10213): a new antiprotozoal agent
Creators: A. B Vaidya - Hindustan Ciba-Geigy Research Centre
D. K Ray - Hindustan Ciba-Geigy Research Centre
N. A Mankodi - Hindustan Ciba-Geigy Research Centre
T Paul - Hindustan Ciba-Geigy Research Centre
U. K Sheth - Hindustan Ciba-Geigy Research Centre
Publication Details: British journal of clinical pharmacology, v 16(5), pp 517-522
Publisher: Blackwell Science
Resource Type: Journal article
Language: English
Academic Unit: Microbiology and Immunology
Web of Science ID: WOS:A1983RP42900009
Scopus ID: 2-s2.0-0021062608
Other Identifier: 991019222778504721

This publication has contributed to the advancement of the following goals:

Data related to this publication, from InCites Benchmarking & Analytics tool: